Roche Holding AG
- Country
- 🇨🇭Switzerland
- Ownership
- Public
- Established
- 1896-01-15
- Employees
- 103.6K
- Market Cap
- $270.5B
- Website
- http://www.roche.com
- Introduction
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.
A Study to Evaluate Efficacy and Safety of Bitopertin in Participants With Persistent, Predominant Negative Symptoms of Schizophrenia
- Conditions
- Schizophrenia
- Interventions
- First Posted Date
- 2010-09-01
- Last Posted Date
- 2017-02-15
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 625
- Registration Number
- NCT01192880
- Locations
- 🇺🇸
Synergy Clinical Research of Escondido, Escondido, California, United States
🇺🇸Excell Research, Oceanside, California, United States
🇺🇸Behavioral Clinical Research Inc., Lauderhill, Florida, United States
A Study of RO4917838 in Participants With Persistent, Predominant Negative Symptoms of Schizophrenia (NN25310)
- Conditions
- Schizophrenia
- Interventions
- First Posted Date
- 2010-09-01
- Last Posted Date
- 2017-06-26
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 629
- Registration Number
- NCT01192867
- Locations
- 🇺🇸
Family Psychiatry of the Woodlands P.A., The Woodlands, Texas, United States
🇺🇸CNRI - Los Angeles, LLC, Pico Rivera, California, United States
🇺🇸Pillar Clinical Research LLC, Dallas, Texas, United States
A Study of Methoxy Polyethylene Glycol-Epoetin Beta (Mircera) for the Treatment of Chronic Renal Anemia in Participants With Diabetic Nephropathy
- Conditions
- Anemia
- Interventions
- Drug: Methoxy polyethylene glycol-epoetin beta [Mircera]
- First Posted Date
- 2010-08-31
- Last Posted Date
- 2018-07-18
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 102
- Registration Number
- NCT01191983
- Locations
- 🇮🇳
Osmania General Hospital; Department of Nephrology, Hyderabad, Andhra Pradesh, India
🇮🇳North Delhi Diabetes Centre, Delhi, India
🇮🇳MAX Balaji Hospital, Delhi, India
A Study of Aleglitazar in Combination With Ibuprofen in Healthy Volunteers
- Conditions
- Healthy Volunteer
- Interventions
- First Posted Date
- 2010-08-25
- Last Posted Date
- 2012-05-22
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 44
- Registration Number
- NCT01188317
A Study of Aleglitazar in Combination With Aspirin in Healthy Volunteers
- First Posted Date
- 2010-08-25
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 44
- Registration Number
- NCT01188304
An Observational Study of the Mean Duration of Trastuzumab (Herceptin) Treatment in Participants With Early or Metastatic Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer
- First Posted Date
- 2010-08-24
- Last Posted Date
- 2017-10-20
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 250
- Registration Number
- NCT01187381
- Locations
- 🇷🇴
Cluj Clinical County Hospital; Oncology Dept, Cluj-Napoca, Romania
A Study of RO5083945 in Combination With Chemotherapy Versus Chemotherapy Alone in Patients With Advanced or Recurrent Non-Small Cell Lung Cancer
- Conditions
- Non-Squamous Non-Small Cell Lung Cancer
- Interventions
- First Posted Date
- 2010-08-20
- Last Posted Date
- 2016-01-01
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 90
- Registration Number
- NCT01185847
A Study of Ritonavir-Boosted Danoprevir (RO5190591) in Combination With Pegasys and Ribavirin in Patients With Chronic Hepatitis C Genotype 1
- Conditions
- Hepatitis C, Chronic
- Interventions
- First Posted Date
- 2010-08-20
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 59
- Registration Number
- NCT01185860
An Observational Study of the Impact of RoActemra/Actemra on Fatigue in Patients With Rheumatoid Arthritis (PEPS)
- Conditions
- Rheumatoid Arthritis
- First Posted Date
- 2010-08-20
- Last Posted Date
- 2016-06-23
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 719
- Registration Number
- NCT01185522
A Study of Danoprevir in Healthy Volunteers And Patients With Hepatic Impairment
- First Posted Date
- 2010-08-20
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 81
- Registration Number
- NCT01185873